Xiaohui Luo

1.8k total citations
56 papers, 1.0k citations indexed

About

Xiaohui Luo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaohui Luo has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaohui Luo's work include Muscle Physiology and Disorders (13 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Xiaohui Luo is often cited by papers focused on Muscle Physiology and Disorders (13 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Xiaohui Luo collaborates with scholars based in China, United States and United Kingdom. Xiaohui Luo's co-authors include Hongbao Liu, Guanqun Ge, Wujun Xue, Xiaohong Wang, Shuibing Liu, Yang Li, Xiaohui Tian, Xiaoming Ding, Lingyi Liang and Puxun Tian and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Xiaohui Luo

49 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohui Luo China 15 312 301 208 170 123 56 1.0k
Vladimir Bogin United States 16 351 1.1× 332 1.1× 303 1.5× 125 0.7× 105 0.9× 27 1.1k
Wenjun Zhang China 17 580 1.9× 244 0.8× 160 0.8× 123 0.7× 183 1.5× 65 1.2k
Dong Ha Bhang South Korea 11 454 1.5× 215 0.7× 372 1.8× 127 0.7× 249 2.0× 18 1.2k
Mary Lou Affronti United States 17 160 0.5× 430 1.4× 117 0.6× 181 1.1× 318 2.6× 58 1.1k
Marleen Renard Belgium 21 347 1.1× 85 0.3× 138 0.7× 232 1.4× 333 2.7× 50 1.5k
Daniel Lee United States 18 523 1.7× 82 0.3× 137 0.7× 140 0.8× 157 1.3× 62 1.5k
José Ramón Ricoy Spain 20 330 1.1× 275 0.9× 151 0.7× 28 0.2× 102 0.8× 50 1.3k
Francesca Megiorni Italy 25 988 3.2× 164 0.5× 310 1.5× 382 2.2× 154 1.3× 65 2.1k
Ignacio Aranda Spain 22 307 1.0× 137 0.5× 263 1.3× 271 1.6× 397 3.2× 95 1.5k
Michael Dobryansky United States 13 299 1.0× 197 0.7× 362 1.7× 89 0.5× 129 1.0× 18 1.2k

Countries citing papers authored by Xiaohui Luo

Since Specialization
Citations

This map shows the geographic impact of Xiaohui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Luo more than expected).

Fields of papers citing papers by Xiaohui Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Luo. The network helps show where Xiaohui Luo may publish in the future.

Co-authorship network of co-authors of Xiaohui Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohui Luo. A scholar is included among the top collaborators of Xiaohui Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohui Luo. Xiaohui Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Wenjie, Guan‐Yu Chen, Zhuang Li, et al.. (2025). Circadian Rhythm Disruption Exacerbates Autoimmune Uveitis: The Essential Role of PER1 in Treg Cell Metabolic Support for Stability and Function. Advanced Science. 12(10). e2400004–e2400004.
3.
Luo, Xiaohui, et al.. (2024). LncRNA GClnc1 promotes osteosarcoma progression by stabilizing NONO and blocking FBXW7-mediated ubiquitination. BMC Cancer. 24(1). 1375–1375. 2 indexed citations
4.
Luo, Xiaohui & Xiang Fei. (2024). Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments. Journal of Thoracic Disease. 16(7). 4727–4741. 3 indexed citations
6.
Li, Jiayu, Cong Ma, Junhong Li, et al.. (2023). LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4. Frontiers in Oncology. 13. 1139588–1139588. 3 indexed citations
8.
Jiang, Wei, et al.. (2023). The synergistic anticancer effect of CBD and DOX in osteosarcoma. Clinical & Translational Oncology. 25(8). 2408–2418. 6 indexed citations
9.
Liang, Lingyi, Xiaohui Luo, Jian Zhang, et al.. (2021). Safety and feasibility of subconjunctival injection of mesenchymal stem cells for acute severe ocular burns: A single-arm study. The Ocular Surface. 22. 103–109. 12 indexed citations
10.
Song, Qiang, et al.. (2021). TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension. Journal of Bioenergetics and Biomembranes. 53(3). 309–320. 15 indexed citations
11.
Luo, Xiaohui, et al.. (2021). Age differences in ocular demodicosis: Demodex profiles and clinical manifestations. Annals of Translational Medicine. 9(9). 791–791. 7 indexed citations
12.
Yi, Qi Long, Yushun Zhang, Xiaohui Luo, et al.. (2020). Efficacy of Patent Foramen Ovale Closure for Treating Migraine: A Prospective Follow-up Study. Journal of Investigative Medicine. 69(1). 7–12. 7 indexed citations
13.
Luo, Xiaohui, et al.. (2020). Subconjunctival injection of tumor necrosis factor-α pre-stimulated bone marrow-derived mesenchymal stem cells enhances anti-inflammation and anti-fibrosis in ocular alkali burns. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(4). 929–940. 15 indexed citations
14.
Zhang, Shun, et al.. (2018). Regulation of the Antioxidant Response by MyoD Transcriptional Coactivator in Castration-resistant Prostate Cancer Cells. Urology. 123. 296.e9–296.e18. 2 indexed citations
15.
Campbell, Craig, Perry B. Shieh, Thomas Sejersen, et al.. (2016). Safety and Tolerability of Ataluren in a Phase 3 Study of Patients with Nonsense Mutation Duchenne Muscular Dystrophy (P3.164). Neurology. 86(16_supplement). 2 indexed citations
16.
McDonald, Craig M., K. Bushby, M. Tulinius, et al.. (2016). Ataluren: An Overview of Clinical Trial Results in Nonsense Mutation Duchenne Muscular Dystrophy (P3.162). Neurology. 86(16_supplement). 2 indexed citations
17.
Lewin, Andrew, et al.. (2013). Nebivolol Monotherapy for Patients With Systolic Stage II Hypertension: Results of a Randomized, Placebo-Controlled Trial. Clinical Therapeutics. 35(2). 142–152. 9 indexed citations
18.
Liu, Hongbao, Shuibing Liu, Yang Li, et al.. (2012). The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury. PLoS ONE. 7(4). e34608–e34608. 226 indexed citations
19.
Li, Yang, Wujun Xue, Xiaohui Tian, et al.. (2011). Improved Survival and Function of Rat Cryopreserved Islets by Coculture With Sertoli Cells. Artificial Organs. 35(6). 634–644. 12 indexed citations
20.
Ge, Guanqun, Puxun Tian, Hongbao Liu, et al.. (2011). Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ Cells. Transplant Immunology. 26(1). 19–26. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026